Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2132 of 5804
-
New hybrid rehab could help PAD patients walk farther and feel better
Symptom relief Not yet recruitingPeripheral artery disease (PAD) is a common atherosclerotic condition characterized by reduced blood flow to the lower extremities, leading to intermittent claudication, decreased walking capacity, and impaired quality of life. Supervised exercise therapy is recommended as the fi…
Phase: NA • Sponsor: Biruni University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New PET scan could spot hidden kidney cancer after treatment
Diagnosis Not yet recruitingThe goal of this clinical trial is to learn whether 89Zr-Girentuximab PET scans can inform management of renal cell carcinoma. The main questions it aims to answer are: * Does the 89Zr-Girentuximab PET detect ccRCC that is left behind or has come back after treatment? * What dif…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Spinal tap could predict lung cancer spread to brain
Knowledge-focused Not yet recruitingThis phase I trial assesses the use of lumbar punctures to detect whether there is circulating tumor deoxyribonucleic acid (ctDNA) in the fluid that surrounds the brain and spinal cord (cerebrospinal fluid) in patients with stage III and IV non-small cell lung cancer (NSCLC). Pat…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Glaucoma surgery gets a patch upgrade: which graft works best?
Disease control Not yet recruitingGlaucoma refers to a group of progressive optic neuropathies that lead to permanent vision loss. Glaucoma is the leading cause of irreversible blindness globally. In 2020, it was estimated to affect 76 million individuals worldwide, with projections indicating this number will ri…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New web tool aims to get anxious teens to open up and ask for help
Symptom relief Not yet recruitingAdolescents frequently experience clinical and subclinical anxiety symptoms, yet many avoid seeking professional help. While universal interventions exist to promote help-seeking, targeted programs for adolescents with elevated anxiety symptoms remain scarce. Therefore, accessibl…
Phase: NA • Sponsor: Aveiro University • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
New hope for tough arthritis cases?
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and the preliminary evidence of disease-modifying effect of BMS-986528 in participants with refractory, difficult-to-treat rheumatoid arthritis (RA).
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a smartphone app replace paper instructions for shoulder surgery patients?
Symptom relief Not yet recruitingThis study is testing whether a smartphone app can help patients better follow instructions before and after shoulder surgery, compared to the usual paper instructions. People from all backgrounds sometimes have trouble understanding or remembering everything needed to prepare f…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Can telehealth bridge the gap for opioid treatment?
Disease control Not yet recruitingThe goal of this pilot trial is to develop and test a telehealth intervention for OUD care delivery and refine measurement strategies. The specific aims are to: 1) identify components of an effective telehealth intervention and barriers to implementation, 2) partner with an advi…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Nature therapy trial aims to ease teen anxiety in 3,000 students
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate the efficacy of a universal intervention based on Natural Psychotherapy in reducing anxiety and depressive symptoms among primary and middle school students. To evaluate both the clinical outcomes and the potential underlying mech…
Phase: NA • Sponsor: Beijing HuiLongGuan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Phone-Based prehab may boost ACL recovery
Disease control Not yet recruitingBackground Prehabilitation prior to anterior cruciate ligament reconstruction (ACLR) has been shown to improve preoperative knee function, enhance quadriceps strength, and optimize postoperative recovery. However, access to supervised prehabilitation programmes remains limited. D…
Phase: NA • Sponsor: Alejandro Caña Pino • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can specialized care centers restore quality of life for women after violence?
Knowledge-focused Not yet recruitingSexual and gender-based violence in France primarily affects women, who make up 88% of victims, with 670,000 affected annually. Many suffer abuse from partners, including 94,000 rape cases, and minors are heavily impacted. Despite frequent emergency visits, medical follow-up is i…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
A simple breathing pattern may ease fibromyalgia symptoms — a trial puts it to the test
Symptom relief Not yet recruitingFibromyalgia is a chronic condition that can cause widespread pain, sleep problems, fatigue, gastrointestinal symptoms, and reduced comfort. This study will evaluate whether box breathing exercise improves sleep quality, pain, gastrointestinal symptoms, and comfort in patients wi…
Phase: NA • Sponsor: Artvin Coruh University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New program aims to stop elder abuse in dementia caregiving
Prevention Not yet recruitingThe Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER) intervention was developed to prevent psychological elder abuse (EA) and promote high-quality caregiving by lowering relationship strain and developing CG resourcefulness. The goal of this two-arm, …
Phase: NA • Sponsor: Case Western Reserve University • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC
-
New Alzheimer's drug 8M2D enters first human safety trials
Disease control Not yet recruitingThis study is testing a new investigational drug called 8M2D to learn whether it is safe and well-tolerated in humans. 8M2D has not previously been given to people. Hypothesis: Researchers believe that 8M2D can be administered safely to healthy adults and to people with early Al…
Phase: PHASE1 • Sponsor: Cenna Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Morning eating and exercise may shield older women from muscle loss
Prevention Not yet recruitingThe aim of TIMEDIAB is to demonstrate that early TRE (eTRE) combined to late (afternoon) exercise will outperform eTRE combined to morning exercise on muscle function as primary endpoint, and glucose homeostasis as secondary endpoint
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Could a fiber from onions and bananas help tame diabetes?
Disease control Not yet recruitingThis study will explore how a natural food ingredient called oligofructose affects blood glucose levels, lipid profiles, inflammation biomarkers, and gut bacteria in Saudi adults with type 2 diabetes. Oligofructose is a type of dietary fiber found in foods such as onions, garlic,…
Phase: NA • Sponsor: Princess Nourah Bint Abdulrahman University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a cream regrow hair lost to frontal fibrosing alopecia?
Disease control Not yet recruitingThis research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational study drug to learn whether the delgocitinib 20 mg/g cream works in treating a specific disease. "Investigational" means that the delgocitinib 20 mg/…
Phase: PHASE2 • Sponsor: Maryanne Makredes Senna • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Bedtime ketone drink tested as new sleep apnea aid
Symptom relief Not yet recruitingObstructive Sleep Apnea (OSA) is a common medical disorder that is associated with reduced quality of life and higher risk of cardiovascular disease. Treatments for OSA and limited and not well tolerated. The investigator's lab has shown that a low carbohydrate, high fat ketogeni…
Phase: PHASE1, PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Can your voice reveal depression? new app puts speech analysis to the test
Diagnosis Not yet recruitingMajor depressive disorder (MDD) and anxiety are increasingly prevalent among university student populations, yet early detection remains reliant on psychometric instruments tied to diagnostic criteria (e.g., PHQ-9, GAD). Emerging evidence suggests that depression affects both the…
Sponsor: Accexible • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Music lessons may sharpen minds in schizophrenia
Symptom relief Recruiting nowSchizophrenia, affecting 1% of the population, is a persistent disorder characterized by varied symptoms. Antipsychotic medications effectively address positive symptoms (delusions, hallucinations) and relapse but have limited impact on negative symptoms (e.g., blunted affect, an…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC